Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Hofseth Biocare Asa News

    0,18 € 0,00% +0,00 €
    26.04.24 12:56:28 Stuttgart aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1JWL4
    ISIN: NO0010598683
    US-Symbol: HOFBF
    Typ: Aktie

    Hofseth Biocare Asa News

    14.07.23 - GlobeNewswire
    Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
    Christel Elise Kanli, primary insider and CFO/COO in Hofseth BioCare ASA («HBC») has today purchased 74,000 shares in HBC at an average price of approx. NOK 2.70 per share.
    30.05.23 - GlobeNewswire
    Hofseth Biocare ASA: ADVANCING THE TREATMENT OF PROSTATE CANCER WITH PUBLICATION OF FTH1 RESEARCH ABSTRACT AHEAD OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) MEETING
    HBC is pleased to announce the online publication of its abstract titled “ Antiproliferative activity of marine-​derived oligopeptides combined with androgen receptor inhibition in ...
    08.12.20 - GlobeNewswire
    Hofseth Biocare ASA: HBC and DKSH announce a Pan-Asian exclusive collaboration for distribution of HBC branded products including across China, India, Japan & Korea
    Ålesund, Norway, 8 th December 2020
    13.10.20 - GlobeNewswire
    Hofseth Biocare ASA: PROGO’s BIOACTIVE PEPTIDES TO SUPPORT HEALTHY IRON LEVELS TO BE LAUNCHED IN THE U.S.
    Hofseth BioCare (HBC) submitted a notification to the Food and Drug Administration (FDA) for the use of six structure function claims for ProGo®’s Bioactive Peptides™. The FDA did ...
    01.09.20 - GlobeNewswire
    Hofseth Biocare ASA: New study highlights the potential of OmeGo® as a prophylactic therapy for Asthma and COPD
    An in-vitro study published in the journal Functional Foods in Health and Disease (2020; 10(8):357-367) shows the therapeutic potential of HBC’s OmeGo® salmon oil for the ...
    01.11.19 - GlobeNewswire
    Hofseth Biocare ASA: Third Quarter 2019 Financial Report
    Hofseth BioCare had operating revenues of NOK 29.2m (16.9m) in the third quarter of 2019.
    18.10.19 - GlobeNewswire
    Hofseth Biocare ASA: ENTERS INTO A CONSULTANCY AGREEMENT WITH JAMES BERGER – CONTEMPLATED US LISTING
    Hofseth BioCare ASA ("HBC") has today entered into a consultancy agreement with James Berger (through his company Nevera AG). Mr. Berger is a dual British and Italian citizen ...
    29.07.19 - GlobeNewswire
    Hofseth Biocare ASA: OVERSUBSCRIBED PRIVATE PLACEMENT SUCCESSFULLY COMPLETED
    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES ...

    Newssuche

    Videos

    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »